Exicure (XCUR) Receivables - Accured (2019 - 2021)
Exicure's (XCUR) quarterly Receivables - Accured came in at $27000.0 in Q3 2021, down 92.95% YoY from $383000.0 in Q3 2020, and down 38.64% on a QoQ basis from $44000.0 in Q2 2021.
Exicure (XCUR) Receivables - Accured (2019 - 2021) Analysis & Trends
Exicure (XCUR) has 3 years of Receivables - Accured data on file, last reported at $27000.0 in Q3 2021.
- Quarterly Receivables - Accured fell 92.95% year-over-year to $27000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $27000.0 (down 92.95% YoY) and the FY2020 annual result came in at $161000.0, down 31.78% from the prior year.
- Receivables - Accured fell to $27000.0 in Q3 2021, from $44000.0 in the prior quarter.
- In the past five years, Receivables - Accured ranged from a high of $398000.0 in Q1 2020 to a low of $27000.0 in Q3 2021.
- A 3-year average of $211750.0 and a median of $222500.0 in 2020 frame the typical range for Receivables - Accured.
- Annual changes were most pronounced in 2020 — Receivables - Accured sank 31.78% — and 2021, when it slumped 92.95%.
- Tracing XCUR's Receivables - Accured over 3 years: stood at $236000.0 in 2019, then slumped by 31.78% to $161000.0 in 2020, then slumped by 83.23% to $27000.0 in 2021.
- The last three Receivables - Accured figures came in at $27000.0 (Q3 2021), $44000.0 (Q2 2021), and $224000.0 (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - | - |
| 10 | Exicure | 8.22 Mn | 8.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 27,000.00 |
| Sep 30, 2021 | 27,000.00 |
| Jun 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 44,000.00 |
| Mar 31, 2021 | 224,000.00 |
| Mar 31, 2021 | 224,000.00 |
| Dec 31, 2020 | 161,000.00 |
| Dec 31, 2020 | 161,000.00 |
| Sep 30, 2020 | 383,000.00 |
| Sep 30, 2020 | 383,000.00 |
| Jun 30, 2020 | 221,000.00 |
| Jun 30, 2020 | 221,000.00 |
| Mar 31, 2020 | 398,000.00 |
| Mar 31, 2020 | 398,000.00 |
| Dec 31, 2019 | 236,000.00 |
| Dec 31, 2019 | 236,000.00 |